OssDsign Past Earnings Performance

Past criteria checks 0/6

OssDsign's earnings have been declining at an average annual rate of -8.8%, while the Medical Equipment industry saw earnings growing at 18.8% annually. Revenues have been growing at an average rate of 42.6% per year.

Key information

-8.8%

Earnings growth rate

36.2%

EPS growth rate

Medical Equipment Industry Growth6.2%
Revenue growth rate42.6%
Return on equity-50.6%
Net Margin-92.2%
Next Earnings Update05 Nov 2024

Recent past performance updates

Recent updates

OssDsign AB (publ) (STO:OSSD) Just Reported Earnings, And Analysts Cut Their Target Price

Aug 23
OssDsign AB (publ) (STO:OSSD) Just Reported Earnings, And Analysts Cut Their Target Price

We Think OssDsign (STO:OSSD) Can Afford To Drive Business Growth

Aug 06
We Think OssDsign (STO:OSSD) Can Afford To Drive Business Growth

Increases to OssDsign AB (publ)'s (STO:OSSD) CEO Compensation Might Cool off for now

Jun 19
Increases to OssDsign AB (publ)'s (STO:OSSD) CEO Compensation Might Cool off for now

Getting In Cheap On OssDsign AB (publ) (STO:OSSD) Is Unlikely

Mar 19
Getting In Cheap On OssDsign AB (publ) (STO:OSSD) Is Unlikely

Here's Why We're Not Too Worried About OssDsign's (STO:OSSD) Cash Burn Situation

Aug 19
Here's Why We're Not Too Worried About OssDsign's (STO:OSSD) Cash Burn Situation

Is OssDsign (STO:OSSD) In A Good Position To Deliver On Growth Plans?

Feb 23
Is OssDsign (STO:OSSD) In A Good Position To Deliver On Growth Plans?

Is OssDsign (STO:OSSD) In A Good Position To Deliver On Growth Plans?

Jul 15
Is OssDsign (STO:OSSD) In A Good Position To Deliver On Growth Plans?

How Much Are OssDsign AB (publ) (STO:OSSD) Insiders Spending On Buying Shares?

Mar 01
How Much Are OssDsign AB (publ) (STO:OSSD) Insiders Spending On Buying Shares?

Revenue & Expenses Breakdown

How OssDsign makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OM:OSSD Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24123-11414232
31 Mar 24118-11814527
31 Dec 23112-13014329
30 Sep 2397-109165-3
30 Jun 2383-951468
31 Mar 2371-991428
31 Dec 2257-9911325
30 Sep 2246-9611117
30 Jun 2238-931150
31 Mar 2233-951070
31 Dec 2132-941040
30 Sep 2129-901000
30 Jun 2127-921000
31 Mar 2123-90940
31 Dec 2025-85920
30 Sep 2024-89960
30 Jun 2022-89970
31 Mar 2022-85940
31 Dec 1918-84900
30 Sep 1918-72800
30 Jun 1920-66730
31 Mar 1921-62680
31 Dec 1821-56630
31 Dec 1716-63520

Quality Earnings: OSSD is currently unprofitable.

Growing Profit Margin: OSSD is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: OSSD is unprofitable, and losses have increased over the past 5 years at a rate of 8.8% per year.

Accelerating Growth: Unable to compare OSSD's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: OSSD is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (38.1%).


Return on Equity

High ROE: OSSD has a negative Return on Equity (-50.61%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies